Ocular Findings in Women With Primary Antiphospholipid Syndrome
NCT03459508 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2018-10-24
Summary
Antiphospholipid antibody syndrome (APS) is an autoimmune disease characterized by systemic thrombosis and bad obstetric history. APS secondary to another medical disorder is the most common. Visual and ocular changes e.g. vaso-occlusive disease of retinal and choroidal vessels are found in patients with secondary APS. Patients with primary APS have also been reported to have ocular changes e.g. retinal vascular occlusion
The aim of our study to detect prevalence of ocular changes in women diagnosed with primary APS and correlation of these changes with adverse obstetric outcome. If a correlation is present, ocular findings in women with APS could be used in the future as a predictor for poor obstetric outcome.
Conditions
- Primary Antiphospholipid Syndrome
Interventions
- DIAGNOSTIC_TEST
-
Ophthalmological examination
Detailed anterior segment examination using slit-lamp biomicroscopy for signs of anterior uveitis, and detailed fundus examination using slit-lamp fundus biomicroscopy with + 90 diopter lens searching for signs of vasculitis and posterior uveitis.
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Ahmed AA Wali, MD · Cairo University
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2018-10-10
- Completion
- 2018-10-23
Countries
- Egypt
Study Locations
More Related Trials
-
The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia
NCT07125599 ·Status: COMPLETED
-
The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations
NCT02855047 ·Status: COMPLETED
-
New Biological Tests in Patients With Antiphospholipid Antibodies
NCT03890601 ·Status: RECRUITING
-
Antiphospholipid Antibodies and Early Severe Preeclampsia.
NCT01538121 ·Status: UNKNOWN
-
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
NCT05679206 ·Status: RECRUITING
-
Establish the Referenc Range of Antiphospholipid Antibody in Healthy Preganany Women
NCT05883189 ·Status: UNKNOWN
-
Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS)
NCT03969498 ·Status: COMPLETED
-
Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?
NCT04274803 ·Status: WITHDRAWN ·Phase: PHASE4
-
Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
NCT00180817 ·Status: COMPLETED
-
Comparing Anterior Segment Parameters During Pregnancy and Post-Pregnancy
NCT05175729 ·Status: COMPLETED
-
Fetal Renal Artery Doppler in Patients With Preeclampsia
NCT06395974 ·Status: COMPLETED
-
Certain Maternal Antibodies in Relation to Doppler in Hypertension With Pregnancy
NCT03214393 ·Status: UNKNOWN
-
The Clinical and Prognostic Features of PRES
NCT05143710 ·Status: COMPLETED
-
Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
NCT01661439 ·Status: UNKNOWN
-
Point-of-care Ultrasound Abnormalities in Early Onset Preeclampsia
NCT05662995 ·Status: UNKNOWN ·Phase: NA
-
Antiphospholipid Antibodies and Fetal Growth Restriction
NCT01538134 ·Status: UNKNOWN
-
Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome
NCT07142239 ·Status: NOT_YET_RECRUITING
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
Diagnostic Value of MicroRNA 210 In Preeclampsia
NCT03193554 ·Status: UNKNOWN
-
Transorbital Ultrasound of Optic Nerve Sheath Diameter Between Healthy Pregnant Women and Those With Severe Preeclampsia.
NCT05594056 ·Status: COMPLETED ·Phase: NA
-
Anxiety and Depressive Symptoms in Placenta Previa / Accreta
NCT05529381 ·Status: COMPLETED
-
Negative Antiphospholipid Syndrome: a Multicentric Study
NCT06373003 ·Status: RECRUITING
-
Vascular Endothelial Factor Gene Polymorphism in Preeclampsia
NCT03500588 ·Status: COMPLETED
-
Maternal Serum Amyloid A Levels in Pregnancies Complicated With Preterm Labour.
NCT03205020 ·Status: UNKNOWN
-
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
NCT03630276 ·Status: UNKNOWN ·Phase: NA